CDCP1 and lung carcinoma: When CL1-0 and A549 lung cancer cells were treated with a miR-1 inhibitor, both CDCP1 RNA levels (Figure 5A and 5B) and CDCP1 protein levels (Figure 5C and 5D) were dramatically increased.